
Sign up to save your podcasts
Or


Last week Teledoc and Livongo, two of the largest telehealth stocks, announced they are merging. The accelerated adoption of telemedicine has pushed their combined market cap from $8 billion to $38 billion in recent months. However, both stocks dropped roughly 20% in the 3 days since the merger announcement.
Was that an overreaction? Is this a buying opportunity? Or does the market know best and anticipate a downside to the merger?
Today on Dumb Money Live we talk to our close friend, investing partner, and favorite medical doctor, Chase Feiger, to better understand the merger and why the market reacted the way it did about these two monster medical-tech companies becoming one.
By Dumb Money4.7
110110 ratings
Last week Teledoc and Livongo, two of the largest telehealth stocks, announced they are merging. The accelerated adoption of telemedicine has pushed their combined market cap from $8 billion to $38 billion in recent months. However, both stocks dropped roughly 20% in the 3 days since the merger announcement.
Was that an overreaction? Is this a buying opportunity? Or does the market know best and anticipate a downside to the merger?
Today on Dumb Money Live we talk to our close friend, investing partner, and favorite medical doctor, Chase Feiger, to better understand the merger and why the market reacted the way it did about these two monster medical-tech companies becoming one.

3,392 Listeners

1,988 Listeners

392 Listeners

1,851 Listeners

2,115 Listeners

355 Listeners

9,844 Listeners

746 Listeners

438 Listeners

133 Listeners

276 Listeners

541 Listeners

499 Listeners

31 Listeners

76 Listeners